Recent Updates
Recently added Catalysts
ATHE Neutral Sentiment Score: 50/100

Appendix 2A - Application for quotation of securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Wednesday

Key Takeaway: Alterity Therapeutics Limited announced a new application for the quotation of securities on January 22, 2025. The application pertains to 95,238 ordinary fully paid shares resulting from the exercise of options. This move is in line with ASX Listing Rules, indicating the company's adherence to regulatory procedures. The existing class of securities includes additional shares listed under code ATH.

Market Sentiment Analysis

Full Press Release Details

ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Wednesday January 22, 2025
+securities to be quoted are:
+Securities issued, transferred
or re-classified as a result of options being exercised or other +convertible securities being converted
Total number of +securities to be quoted
ASX + security code Security description Number of +securities to be quoted Issue date
ATH ORDINARY FULLY PAID 95,238 22/01/2025
Refer to next page for full details of the announcement
Part 1 - Entity and announcement details
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) apply for +quotation of
the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 Registered number type Registration number
ACN 080699065
Date of this announcement
Part 2 - Type of Issue
+securities to be quoted are:
transferred or re-classified as a result of options being exercised or other +convertible securities being converted
of +securities to be quoted is:
Additional +securities in a class that is already quoted
on ASX ("existing class")
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B
Existing +securities converting into additional +securities
in an existing class
FROM (Existing Class)
ASX +security code and description
ATHO : OPTION EXPIRING 31-AUG-2026
ASX +security code and description
ATH : ORDINARY FULLY PAID
Please state the number of options that were exercised or other +convertible securities that were converted The first date the options were exercised or other +convertible securities were converted The last date the options were exercised or other +convertible securities were converted
95,238 20/1/2025
Is this all of the options or other +convertible securities
on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?
The right of the holder of the options or other +convertible
securities to receive the +underlying securities is being satisfied by:
An issue of new +securities
The underlying +securities being received by the holder
Intended to be, but are not yet, quoted by ASX
Were the options being exercised or other +convertible
securities being converted issued under an +employee incentive scheme?
Will the +securities to be quoted rank equally in all
respects from their issue date with the existing issued +securities in that class?
Number of +securities to be quoted
Are the +securities being issued for a cash consideration?
In what currency is the cash consideration being paid?
What is the issue price per +security?
information the entity wishes to provide about the +securities to be quoted
Part 4 - Issued capital following quotation
quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix
2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities
(total number of each +class of +securities quoted on ASX following the +quotation of the+securities subject of this application)
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 5,320,431,356
ATHO : OPTION EXPIRING 31-AUG-2026 932,611,430
+securities (Total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 14,250,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01 170,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 26,500,000
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 120,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720

Frequently Asked Questions

When did Alterity Therapeutics announce the new securities?

The announcement was made on January 22, 2025.

What type of securities are being quoted?

Ordinary fully paid securities are being quoted.

How many additional securities are to be quoted?

A total of 95,238 additional securities are to be quoted.

What is the ASX code for the ordinary fully paid securities?

The ASX code for ordinary fully paid securities is ATH.

What is the issue date for the new securities?

The issue date for the new securities is January 22, 2025.

Last updated: Jan 22, 2025